Today: 29 January 2026
Subscribe
Browse Category

Healthcare Stocks News 2 January 2026 - 27 January 2026

Abbott stock price today: ABT slips as CEO buy hits SEC filing after volatile week

Abbott stock price today: ABT slips as CEO buy hits SEC filing after volatile week

New York, Jan 27, 2026, 12:35 ET — Regular session Shares of Abbott Laboratories dropped roughly 1.2% to $107.49 by midday Tuesday, erasing some of Monday’s gains. A Form 4 filing dated Jan. 26 revealed that Chairman and CEO Robert Ford purchased 18,800 shares on Jan. 23. (SEC) The stock’s volatility is significant as Abbott continues to grapple with fallout…
27 January 2026
·····
Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

New York, Jan 27, 2026, 05:58 (EST) — Premarket Dow futures slipped early Tuesday as UnitedHealth fell on news of a proposed Medicare Advantage rate update. Meanwhile, S&P 500 and Nasdaq futures climbed, with investors gearing up for a packed earnings slate and the start of the Federal Reserve meeting. By 5:22 a.m. ET, Dow E-minis were down 40 points,…
27 January 2026
······
Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade

Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade

New York, Jan 26, 2026, 21:03 EST — Market closed. Shares of Boston Scientific Corp climbed 1.12% to $93.55 on Monday, while the S&P 500 edged up 0.50% and the Dow Jones Industrial Average gained 0.64%. The stock underperformed Abbott Laboratories and Stryker but outpaced Medtronic. Trading volume stayed above its 50-day average. Despite Monday’s gain, shares remain roughly 14.6%…
27 January 2026
·····
Abbott Laboratories stock faces a Monday test as ABT hovers near a 52-week low

Abbott Laboratories stock faces a Monday test as ABT hovers near a 52-week low

New York, January 25, 2026, 15:23 EST — Market closed Abbott Laboratories shares head into Monday weighed down, following last week’s selloff and another wave of broker price-target downgrades. Timing is crucial. Abbott, known as a defensive healthcare stock, suddenly saw its volatility spike, pushing portfolio managers to rethink their “steady compounder” stance just as the market prepares for a…
25 January 2026
····
Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

NEW YORK, Jan 23, 2026, 13:25 EST — Regular session Intuitive Surgical shares slipped roughly 0.2% to $524.65 on Friday, retreating from an early gain. The surgical-robot maker reported a fourth-quarter beat but tempered expectations with a 2026 outlook signaling slower growth in its core da Vinci procedures. Why this matters now: procedure growth—the count of operations performed with da…
23 January 2026
·····
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

NEW YORK, Jan 22, 2026, 05:43 EST — Premarket PAVmed Inc shares slipped 3.4% in premarket Thursday, down to $11.64 after a volatile session the previous day. On Wednesday, the micro-cap medical tech stock surged 94.7%, closing at $12.05 after trading between $11.58 and $28.44 on heavy volume. (Stockanalysis) The rally stands out, especially with PAVmed’s small float and limited…
22 January 2026
····
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

New York, Jan 18, 2026, 10:37 EST — Market closed. Johnson & Johnson shares slipped 0.4% to $218.66 on Friday, the last session before U.S. markets shut for the Martin Luther King Jr. Day holiday. (Yahoo Finance) The stock heads into the week with investors leaning hard on earnings to justify valuations. “The most important thing right now is earnings,”…
18 January 2026
··········
Johnson & Johnson stock price: 3 things to watch before JNJ earnings after Friday dip

Johnson & Johnson stock price: 3 things to watch before JNJ earnings after Friday dip

New York, January 17, 2026, 10:34 EST — Market closed Johnson & Johnson shares edged down 0.41% Friday, finishing at $218.66, as U.S. healthcare stocks struggled. Pfizer slipped 0.93%, while Merck tumbled 1.93% during the session. (MarketWatch) The market pulled back amid choppy trading ahead of the long weekend. The S&P 500 finished almost unchanged, with the healthcare sector dragging…
17 January 2026
·····
Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

New York, January 13, 2026, 12:13 PM EST — Regular session Option Care Health shares jumped nearly 10% Tuesday following the release of preliminary fourth-quarter results, a first look at its 2026 forecast, and an increase in its share buyback plan. The stock last traded up 9.7% at $35.16. The update arrives as investors scramble to gauge the year ahead…
13 January 2026
·····
Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

New York, January 12, 2026, 10:25 EST — Regular session Jaguar Health, Inc (NASDAQ: JAGX) shares dropped roughly 9% Monday after announcing a U.S. licensing deal with an affiliate of private company Future Pak, potentially generating up to $38 million for its crofelemer products. The stock last traded near $0.96, after earlier surging as much as 38%, fluctuating between $0.94…
12 January 2026
···
UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

New York, Jan 5, 2026, 18:23 EST — After-hours UnitedHealth Group Inc (UNH.N) shares rose 1.7% on Monday to $342.02, after Barclays lifted its price target on the insurer. The move matters because UnitedHealth has been a re-rating story: the stock remains far below its 52-week high and investors are looking for signs that 2026 margins can stabilize. UnitedHealth’s 52-week…
6 January 2026
·····
Johnson & Johnson stock today: JNJ nudges lower after $1.30 dividend as earnings loom

Johnson & Johnson stock today: JNJ nudges lower after $1.30 dividend as earnings loom

New York, January 2, 2026, 12:21 ET — Regular session Johnson & Johnson shares edged lower on Friday after the healthcare conglomerate declared its first-quarter dividend, leaving the stock little changed on the first trading day of 2026. Jnj The muted reaction reflects how investors use dividend announcements less as a surprise catalyst and more as a signal of steady…
2 January 2026
·····
1 2 3 … 6

Stock Market Today

  • Euronext Dublin Announces Delisting of Fair Oaks Loan Funding V DAC
    January 29, 2026, 10:12 AM EST. Euronext Dublin has issued a notice of delisting for Fair Oaks Loan Funding V Designated Activity Company (DAC). The move marks the removal of the company's securities from trading on the Irish stock exchange. This development follows regulatory procedures overseen by Euronext Dublin, aiming to maintain market integrity. Investors holding Fair Oaks Loan Funding V DAC shares should review their positions accordingly. The delisting may impact liquidity and trading activities, highlighting the need for vigilant portfolio management. Ongoing updates will be provided through official channels to keep market participants informed.
Go toTop